High-volume hybridoma sequencing on the NeuroMabSeq platform enables efficient generation of recombinant monoclonal antibodies and scFvs for neuroscience research. Mitchell KG, Gong B, Hunter SS, Burkart-Waco D, Gavira-O’Neill CE, Templeton KM, Goethel ME, Bzymek M, MacNiven LM, Murray KD, Settles ML, Froenicke L, Trimmer JS. Sci Rep. 2023 Sep 27;13(1):16200. doi: 10.1038/s41598-023-43233-4. PMID: 37758930
NeuroMabSeq: high volume acquisition, processing, and curation of hybridoma sequences and their use in generating recombinant monoclonal antibodies and scFvs for neuroscience research. Mitchell KG, Gong B, Hunter SS, Burkart-Waco D, Gavira-O’Neill CE, Templeton KM, Goethel ME, Bzymek M, MacNiven LM, Murray KD, Settles ML, Froenicke L, Trimmer JS. bioRxiv [Preprint]. 2023 Jun 30:2023.06.28.546392. doi: 10.1101/2023.06.28.546392. PMID: 37425915
Identification of a S-(2-succino)cysteine breakdown pathway that uses a novel S-(2-succino) lyase. Hillmann KB, Goethel ME, Erickson NA, Niehaus TD. J Biol Chem. 2022 Dec;298(12):102639. doi: 10.1016/j.jbc.2022.102639. Epub 2022 Oct 27. PMID: 36309089
